Captrust Financial Advisors Maravai Lifesciences Holdings, Inc. Transaction History

Captrust Financial Advisors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$4.7 - $9.87 $179,206 - $376,333	38,129 New	38,129 $249,000
Q3 2022 Nov 16, 2022	SELL	$20.6 - $30.37 $101,702 - $149,936	-4,937 Reduced 14.12%	30,036 $767,000
Q2 2022 Aug 23, 2022	SELL	$26.05 - $37.48 $8,883 - $12,780	-341 Reduced 0.97%	34,973 $994,000
Q2 2022 Aug 16, 2022	BUY	$26.05 - $37.48 $46,342 - $66,676	1,779 Added 5.3%	35,314 $1 Million
Q1 2022 May 16, 2022	BUY	$24.46 - $40.92 $10,811 - $18,086	442 Added 1.34%	33,535 $1.18 Million
Q4 2021 Feb 14, 2022	BUY	$35.0 - $45.94 $439,075 - $576,317	12,545 Added 61.05%	33,093 $1.39 Million
Q3 2021 Nov 16, 2021	BUY	$36.8 - $60.62 $409,547 - $674,639	11,129 Added 118.15%	20,548 $1.01 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $45.0 $100,885 - $139,860	3,108 Added 49.25%	9,419 $393,000
Q1 2021 May 17, 2021	BUY	$25.8 - $38.49 $162,823 - $242,910	6,311 New	6,311 $225,000

235

141M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $739M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.